Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Exploring iron-binding to human frataxin and to selected Friedreich ataxia mutants by means of NMR and EPR spectroscopies.

Bellanda M, Maso L, Doni D, Bortolus M, De Rosa E, Lunardi F, Alfonsi A, Noguera ME, Herrera MG, Santos J, Carbonera D, Costantini P.

Biochim Biophys Acta Proteins Proteom. 2019 Nov;1867(11):140254. doi: 10.1016/j.bbapap.2019.07.007. Epub 2019 Jul 22.

2.

Liposomes containing biosurfactants isolated from Lactobacillus gasseri exert antibiofilm activity against methicillin resistant Staphylococcus aureus strains.

Giordani B, Costantini PE, Fedi S, Cappelletti M, Abruzzo A, Parolin C, Foschi C, Frisco G, Calonghi N, Cerchiara T, Bigucci F, Luppi B, Vitali B.

Eur J Pharm Biopharm. 2019 Jun;139:246-252. doi: 10.1016/j.ejpb.2019.04.011. Epub 2019 Apr 13.

PMID:
30991089
3.

Overview of the Maturation Machinery of the H-Cluster of [FeFe]-Hydrogenases with a Focus on HydF.

Bortolus M, Costantini P, Doni D, Carbonera D.

Int J Mol Sci. 2018 Oct 11;19(10). pii: E3118. doi: 10.3390/ijms19103118. Review.

4.

Biophysical characterisation of the recombinant human frataxin precursor.

Castro IH, Ferrari A, Herrera MG, Noguera ME, Maso L, Benini M, Rufini A, Testi R, Costantini P, Santos J.

FEBS Open Bio. 2018 Jan 25;8(3):390-405. doi: 10.1002/2211-5463.12376. eCollection 2018 Mar.

5.

Identifying conformational changes with site-directed spin labeling reveals that the GTPase domain of HydF is a molecular switch.

Galazzo L, Maso L, De Rosa E, Bortolus M, Doni D, Acquasaliente L, De Filippis V, Costantini P, Carbonera D.

Sci Rep. 2017 May 10;7(1):1714. doi: 10.1038/s41598-017-01886-y.

6.

Comprehensive mapping of the Helicobacter pylori NikR regulon provides new insights in bacterial nickel responses.

Vannini A, Pinatel E, Costantini PE, Pelliciari S, Roncarati D, Puccio S, De Bellis G, Peano C, Danielli A.

Sci Rep. 2017 Apr 10;7:45458. doi: 10.1038/srep45458.

7.

[NiFe]-hydrogenase is essential for cyanobacterium Synechocystis sp. PCC 6803 aerobic growth in the dark.

De Rosa E, Checchetto V, Franchin C, Bergantino E, Berto P, Szabò I, Giacometti GM, Arrigoni G, Costantini P.

Sci Rep. 2015 Jul 28;5:12424. doi: 10.1038/srep12424.

8.

Probing the Solvent Accessibility of the [4Fe-4S] Cluster of the Hydrogenase Maturation Protein HydF from Thermotoga neapolitana by HYSCORE and 3p-ESEEM.

Albertini M, Berto P, Vallese F, Di Valentin M, Costantini P, Carbonera D.

J Phys Chem B. 2015 Oct 29;119(43):13680-9. doi: 10.1021/acs.jpcb.5b03110. Epub 2015 May 27.

PMID:
25978307
9.

Do elderly patients call 911 when presented with clinical scenarios suggestive of acute stroke? A cross-sectional study.

Caruso D, Perez Akly M, Costantini PD, Fridman S, Esnaola MM.

Cerebrovasc Dis. 2015;39(2):87-93. doi: 10.1159/000369962. Epub 2015 Jan 8.

10.

Pandemic 2009 Influenza A (H1N1) virus infection in cancer and hematopoietic stem cell transplant recipients; a multicenter observational study.

Dignani MC, Costantini P, Salgueira C, Jordán R, Guerrini G, Valledor A, Herrera F, Nenna A, Mora C, Roccia-Rossi I, Stecher D, Carbone E, Laborde A, Efron E, Altclas J, Calmaggi A, Cozzi J.

Version 2. F1000Res. 2014 Sep 12 [revised 2015 Jan 1];3:221. doi: 10.12688/f1000research.5251.2. eCollection 2014.

11.

Increase in mortality rate in patients with dementia treated with atypical antipsychotics: a cohort study in outpatients in Central Italy.

Piersanti M, Capannolo M, Turchetti M, Serroni N, De Berardis D, Evangelista P, Costantini P, Orsini A, Rossi A, Maggio R.

Riv Psichiatr. 2014 Jan-Feb;49(1):34-40. doi: 10.1708/1407.15623.

PMID:
24572582
12.

The [4Fe-4S]-cluster coordination of [FeFe]-hydrogenase maturation protein HydF as revealed by EPR and HYSCORE spectroscopies.

Berto P, Di Valentin M, Cendron L, Vallese F, Albertini M, Salvadori E, Giacometti GM, Carbonera D, Costantini P.

Biochim Biophys Acta. 2012 Dec;1817(12):2149-57. doi: 10.1016/j.bbabio.2012.09.004. Epub 2012 Sep 14.

13.

Biochemical analysis of the interactions between the proteins involved in the [FeFe]-hydrogenase maturation process.

Vallese F, Berto P, Ruzzene M, Cendron L, Sarno S, De Rosa E, Giacometti GM, Costantini P.

J Biol Chem. 2012 Oct 19;287(43):36544-55. doi: 10.1074/jbc.M112.388900. Epub 2012 Aug 29.

14.

Crystal structure of HydF scaffold protein provides insights into [FeFe]-hydrogenase maturation.

Cendron L, Berto P, D'Adamo S, Vallese F, Govoni C, Posewitz MC, Giacometti GM, Costantini P, Zanotti G.

J Biol Chem. 2011 Dec 23;286(51):43944-50. doi: 10.1074/jbc.M111.281956. Epub 2011 Nov 4.

15.

The cyanobacterium Synechocystis sp. PCC 6803 is able to express an active [FeFe]-hydrogenase without additional maturation proteins.

Berto P, D'Adamo S, Bergantino E, Vallese F, Giacometti GM, Costantini P.

Biochem Biophys Res Commun. 2011 Feb 25;405(4):678-83. doi: 10.1016/j.bbrc.2011.01.095. Epub 2011 Feb 1.

PMID:
21284939
16.

The mitochondrial effects of small organic ligands of BCL-2: sensitization of BCL-2-overexpressing cells to apoptosis by a pyrimidine-2,4,6-trione derivative.

Milanesi E, Costantini P, Gambalunga A, Colonna R, Petronilli V, Cabrelle A, Semenzato G, Cesura AM, Pinard E, Bernardi P.

J Biol Chem. 2006 Apr 14;281(15):10066-72. Epub 2006 Feb 14.

17.

Study of the effect of ion channel modulators on photosynthetic oxygen evolution.

Segalla A, Szabo I, Costantini P, Giacometti GM.

J Chem Inf Model. 2005 Nov-Dec;45(6):1691-700.

PMID:
16309275
18.

Functional insights from the structural modelling of a small Fe-hydrogenase.

Tosatto SC, Giacometti GM, Valle G, Costantini P.

Biochem Biophys Res Commun. 2006 Jan 6;339(1):277-83. Epub 2005 Nov 10.

PMID:
16297868
19.

Modification of permeability transition pore arginine(s) by phenylglyoxal derivatives in isolated mitochondria and mammalian cells. Structure-function relationship of arginine ligands.

Johans M, Milanesi E, Franck M, Johans C, Liobikas J, Panagiotaki M, Greci L, Principato G, Kinnunen PK, Bernardi P, Costantini P, Eriksson O.

J Biol Chem. 2005 Apr 1;280(13):12130-6. Epub 2005 Jan 24.

20.

Palmitate induces apoptosis via a direct effect on mitochondria.

de Pablo MA, Susin SA, Jacotot E, Larochette N, Costantini P, Ravagnan L, Zamzami N, Kroemer G.

Apoptosis. 1999 Apr;4(2):81-7.

PMID:
14634285
21.

[Reliability of extemporaneous histological sentinel lymph node examination during breast surgery for neoplasia].

Tinti A, Lucertini M, Costantini PG, Coschiera P, Spinelli, Stafoggia P.

Tumori. 2003 Jul-Aug;89(4 Suppl):200-2. Italian.

PMID:
12903593
22.

[172 consecutive total gastrectomies for gastric cancer with Roux-en-Y loop reconstruction and without fistulization of the esophago-jejunal anastomosis].

Cicetti M, Corinaldesi F, Costantini PG, Stafoggia P, Tamburini A, Tinti A.

Tumori. 2003 Jul-Aug;89(4 Suppl):29-31. Review. Italian.

PMID:
12903538
23.

Conventional chest radiography in the initial assessment of adult cancer patients with fever and neutropenia.

Navigante AH, Cerchietti LC, Costantini P, Salgado H, Castro MA, Lutteral MA, Cabalar ME.

Cancer Control. 2002 Jul-Aug;9(4):346-51. No abstract available.

PMID:
12228760
24.

Pre-processed caspase-9 contained in mitochondria participates in apoptosis.

Costantini P, Bruey JM, Castedo M, Métivier D, Loeffler M, Susin SA, Ravagnan L, Zamzami N, Garrido C, Kroemer G.

Cell Death Differ. 2002 Jan;9(1):82-8.

25.

NADH oxidase activity of mitochondrial apoptosis-inducing factor.

Miramar MD, Costantini P, Ravagnan L, Saraiva LM, Haouzi D, Brothers G, Penninger JM, Peleato ML, Kroemer G, Susin SA.

J Biol Chem. 2001 May 11;276(19):16391-8. Epub 2001 Feb 13.

26.

GD3 ganglioside as an intracellular mediator of apoptosis.

Rippo MR, Malisan F, Ravagnan L, Tomassini B, Condò I, Costantini P, Susin SA, Rufini A, Todaro M, Kroemer G, Testi R.

Eur Cytokine Netw. 2000 Sep;11(3):487-8. No abstract available.

PMID:
11203187
27.

Bid acts on the permeability transition pore complex to induce apoptosis.

Zamzami N, El Hamel C, Maisse C, Brenner C, Muñoz-Pinedo C, Belzacq AS, Costantini P, Vieira H, Loeffler M, Molle G, Kroemer G.

Oncogene. 2000 Dec 14;19(54):6342-50.

PMID:
11175349
28.

GD3 ganglioside directly targets mitochondria in a bcl-2-controlled fashion.

Rippo MR, Malisan F, Ravagnan L, Tomassini B, Condo I, Costantini P, Susin SA, Rufini A, Todaro M, Kroemer G, Testi R.

FASEB J. 2000 Oct;14(13):2047-54.

PMID:
11023989
29.

Two distinct pathways leading to nuclear apoptosis.

Susin SA, Daugas E, Ravagnan L, Samejima K, Zamzami N, Loeffler M, Costantini P, Ferri KF, Irinopoulou T, Prévost MC, Brothers G, Mak TW, Penninger J, Earnshaw WC, Kroemer G.

J Exp Med. 2000 Aug 21;192(4):571-80.

30.

Mitochondrion as a novel target of anticancer chemotherapy.

Costantini P, Jacotot E, Decaudin D, Kroemer G.

J Natl Cancer Inst. 2000 Jul 5;92(13):1042-53. Review.

PMID:
10880547
31.

Mitochondrial membrane permeabilization during the apoptotic process.

Jacotot E, Costantini P, Laboureau E, Zamzami N, Susin SA, Kroemer G.

Ann N Y Acad Sci. 1999;887:18-30. Review.

PMID:
10668461
32.

Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis.

Costantini P, Belzacq AS, Vieira HL, Larochette N, de Pablo MA, Zamzami N, Susin SA, Brenner C, Kroemer G.

Oncogene. 2000 Jan 13;19(2):307-14.

33.

The novel retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphtalene carboxylic acid can trigger apoptosis through a mitochondrial pathway independent of the nucleus.

Marchetti P, Zamzami N, Joseph B, Schraen-Maschke S, Méreau-Richard C, Costantini P, Métivier D, Susin SA, Kroemer G, Formstecher P.

Cancer Res. 1999 Dec 15;59(24):6257-66.

34.

The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore.

Jacotot E, Ravagnan L, Loeffler M, Ferri KF, Vieira HL, Zamzami N, Costantini P, Druillennec S, Hoebeke J, Briand JP, Irinopoulou T, Daugas E, Susin SA, Cointe D, Xie ZH, Reed JC, Roques BP, Kroemer G.

J Exp Med. 2000 Jan 3;191(1):33-46.

35.

Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore.

Ravagnan L, Marzo I, Costantini P, Susin SA, Zamzami N, Petit PX, Hirsch F, Goulbern M, Poupon MF, Miccoli L, Xie Z, Reed JC, Kroemer G.

Oncogene. 1999 Apr 22;18(16):2537-46.

36.

Molecular characterization of mitochondrial apoptosis-inducing factor.

Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G.

Nature. 1999 Feb 4;397(6718):441-6.

PMID:
9989411
37.

The mitochondrial permeability transition.

Bernardi P, Colonna R, Costantini P, Eriksson O, Fontaine E, Ichas F, Massari S, Nicolli A, Petronilli V, Scorrano L.

Biofactors. 1998;8(3-4):273-81. Review.

PMID:
9914829
39.

Gram-positive infections and quinolones in neutropenia.

Altclas J, Costantini P.

Ann Intern Med. 1997 May 15;126(10):830; author reply 831. No abstract available.

PMID:
9148665
40.

Preclinical evaluation of group B Neisseria meningitidis and Escherichia coli K92 capsular polysaccharide-protein conjugate vaccines in juvenile rhesus monkeys.

Devi SJ, Zollinger WD, Snoy PJ, Tai JY, Costantini P, Norelli F, Rappuoli R, Frasch CE.

Infect Immun. 1997 Mar;65(3):1045-52.

41.

Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites.

Costantini P, Chernyak BV, Petronilli V, Bernardi P.

J Biol Chem. 1996 Mar 22;271(12):6746-51.

42.

Potential role of cyclosporin A-sensitive mitochondrial channels in ischemia-reperfusion injury.

Nicolli A, costantini P, Basso E, Colonna R, Petronilli V, Bernardi P.

Transplant Proc. 1995 Oct;27(5):2825-6. No abstract available.

PMID:
7482931
44.
45.

Regulation of the permeability transition pore, a voltage-dependent mitochondrial channel inhibited by cyclosporin A.

Petronilli V, Nicolli A, Costantini P, Colonna R, Bernardi P.

Biochim Biophys Acta. 1994 Aug 30;1187(2):255-9.

PMID:
7521212
47.

Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study.

Packer M, Gheorghiade M, Young JB, Costantini PJ, Adams KF, Cody RJ, Smith LK, Van Voorhees L, Gourley LA, Jolly MK.

N Engl J Med. 1993 Jul 1;329(1):1-7.

48.

HLA antigens and clinical manifestations in Crohn's disease.

Modena V, Amoroso A, Frattasio C, Pera A, Costantini P, Maiocco I, Ponti V, Di Vittorio CC, Verme G, Curtoni ES.

Clin Exp Rheumatol. 1988 Jul-Sep;6(3):221-5.

PMID:
3180544
49.

[Therapeutic tactics in pancreatic injuries. Clinical contribution].

Saba V, Orazietti L, Manna G, Costantini PG, Venerucci R.

Minerva Chir. 1988 Jan 31;43(1-2):79-82. Italian. No abstract available.

PMID:
3362396
50.

Primary biliary cirrhosis and rheumatic diseases: a clinical, immunological and immunogenetical study.

Modena V, Marengo C, Amoroso A, Rosina F, Costantini P, Bellando P, Coppo R, Rizzetto M.

Clin Exp Rheumatol. 1986 Apr-Jun;4(2):129-34.

PMID:
3488154

Supplemental Content

Loading ...
Support Center